CTLA4 Haploinsufficiency
3 clinical trials · Condition
◉ Watch CTLA4 Haploinsufficiency
| Record | Firm | Date |
|---|---|---|
| Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor (NCT05235438) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-06-15 |
| Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency (NCT05040256) | University Hospital, Montpellier | 2021-02-01 |
| New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies (NCT04377867) | Marmara University | 2020-01-15 |
Track CTLA4 Haploinsufficiency automatically
Every clearance here is in the API, with alerts when new ones post.